Propoxyphene (PPX) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Propoxyphene (PPX) antibodies (anti-Propoxyphene, anti-PPX) and diagnostic hapten-carrier conjugates BSA-Propoxyphene (PPX), OVA-Propoxyphene (PPX), KLH-Propoxyphene (PPX) antigens for Pain PPX detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-241-Ag01 | BSA-Propoxyphene (PPX) | 756 |
GMP-SMT-241-Ag02 | OVA-Propoxyphene (PPX) | 756 |
GMP-SMT-241-Ab01 | Anti-human Propoxyphene (PPX) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-241-Ab02 | Anti-human Propoxyphene (PPX) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-241-Ag01 |
Product Name | BSA-Propoxyphene (PPX) |
Target/Biomarker | Propoxyphene (PPX) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Propoxyphene (PPX) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PPX level test of Pain () and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Propoxyphene (PPX) / OVA-Propoxyphene (PPX) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-241-Ag02 |
Product Name | OVA-Propoxyphene (PPX) |
Target/Biomarker | Propoxyphene (PPX) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Propoxyphene (PPX) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PPX level test of Pain () and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Propoxyphene (PPX) / OVA-Propoxyphene (PPX) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-241-Ab01 |
Product Name | Anti-human Propoxyphene (PPX) mouse monoclonal antibody (mAb) |
Target/Biomarker | Propoxyphene (PPX) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Propoxyphene (PPX) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PPX level test of Pain () and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Propoxyphene (PPX) / OVA-Propoxyphene (PPX) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-241-Ab02 |
Product Name | Anti-human Propoxyphene (PPX) human monoclonal antibody (mAb) |
Target/Biomarker | Propoxyphene (PPX) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Propoxyphene (PPX) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PPX level test of Pain () and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Propoxyphene (PPX) / OVA-Propoxyphene (PPX) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
1. Propoxyphene: A Comprehensive Examination in In Vitro Diagnosis (IVD) Propoxyphene, a synthetic opioid analgesic, has historically played a significant role in pain management, particularly for individuals experiencing mild to moderate pain. However, its usage has been overshadowed by safety concerns, notably the potential for overdose, leading to its withdrawal from the pharmaceutical market in several countries. Within the realm of in vitro diagnosis (IVD), Propoxyphene serves as a crucial target molecule for diagnostic assays, addressing a spectrum of clinical and forensic applications. Our distinguished biopharmaceutical company is at the forefront of delivering a comprehensive suite of resources meticulously tailored for the precise measurement and detection of Propoxyphene. This specialized portfolio encompasses anti-Propoxyphene antibodies and an expansive array of small molecule competitive antigens. These encompass Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated forms. These meticulously engineered reagents are intricately designed to facilitate the development of advanced diagnostic assays, enabling the accurate and sensitive measurement of Propoxyphene levels in diverse biological samples, ranging from urine to blood. 2. The Multifaceted Significance of Measuring Propoxyphene The measurement of Propoxyphene is marked by its profound significance across a spectrum of compelling clinical, forensic, and research-based reasons: a. Enhanced Patient Safety: In situations where Propoxyphene may still be prescribed, accurate measurement of its levels is paramount. This ensures that patients receive the appropriate dosage, minimizing the risk of toxicity and optimizing patient safety. b. Substance Monitoring: Propoxyphene measurement is a valuable tool for healthcare providers to monitor patient adherence and detect any misuse or non-compliance. This is particularly pertinent in cases where the drug is prescribed for pain management or other therapeutic purposes. c. Forensic and Postmortem Analysis: Propoxyphene testing assumes a pivotal role in forensic investigations and postmortem analysis. It enables the determination of the drug's presence in biological specimens, contributing to our understanding of its involvement in medical emergencies or fatalities. This information can be crucial in legal proceedings and investigations. d. Pharmacokinetics Studies: Propoxyphene measurement is instrumental in the realm of pharmacokinetic research. It allows researchers to gain a comprehensive understanding of the drug's metabolism, distribution, and elimination from the body. This knowledge is invaluable for drug development, safety assessments, and pharmacological research. In summary, the meticulous measurement of Propoxyphene is an indispensable and multifaceted component within the expansive field of in vitro diagnosis (IVD). It significantly contributes to patient safety, substance monitoring, forensic investigations, and the advancement of pharmacological research. Our specialized product portfolio, meticulously tailored for Propoxyphene testing, occupies a central role in enabling precise and sensitive quantification. This, in turn, advances patient care, enhances safety, and bolsters the capabilities of forensic analysis and pharmaceutical research, ultimately driving scientific progress and medical excellence.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.